Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.2756
-0.2674 (-49.24%)
At close: Apr 9, 2025, 4:00 PM
0.2654
-0.0102 (-3.70%)
Pre-market: Apr 10, 2025, 9:24 AM EDT
Vincerx Pharma Market Cap
Vincerx Pharma has a market cap or net worth of $1.44 million as of April 10, 2025. Its market cap has decreased by -98.64% in one year.
Market Cap
1.44M
Enterprise Value
-3.54M
1-Year Change
-98.64%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since May 27, 2020, Vincerx Pharma's market cap has decreased from $22.32M to $1.44M, a decrease of -93.54%. That is a compound annual growth rate of -43.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2025 | 1.44M | -83.69% |
| Dec 31, 2024 | 8.84M | -64.95% |
| Dec 29, 2023 | 25.23M | 16.73% |
| Dec 30, 2022 | 21.61M | -89.91% |
| Dec 31, 2021 | 214.20M | -26.75% |
| Dec 31, 2020 | 292.41M | 1,210.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 676.82B |
| UnitedHealth Group | 529.16B |
| Johnson & Johnson | 363.81B |
| AbbVie | 318.13B |
| Novo Nordisk | 265.62B |
| Abbott Laboratories | 220.33B |
| Merck & Co. | 206.91B |
| AstraZeneca | 191.67B |